Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
AlphaLISA SureFire Ultra Human Total IR-β (Insulin Receptor Beta) Detection Kit, 500 Assay Points
View All
AlphaLISA SureFire Ultra Human Total IR-β (Insulin Receptor Beta) Detection Kit, 500 Assay Points
The AlphaLISA™ SureFire® Ultra™ total Insulin Receptor β assay is a sandwich immunoassay for quantitative detection of total Insulin Receptor β in cellular lysates using Alpha Technology. This assay is intended to be a normalization or control assay in conjunction with the AlphaLISA SureFire phospho-Insulin Receptor β assay.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
| Feature | Specification |
|---|---|
| Application | Cell Signaling |
| Sample Volume | 10 µL |
The AlphaLISA™ SureFire® Ultra™ total Insulin Receptor β assay is a sandwich immunoassay for quantitative detection of total Insulin Receptor β in cellular lysates using Alpha Technology. This assay is intended to be a normalization or control assay in conjunction with the AlphaLISA SureFire phospho-Insulin Receptor β assay.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
AlphaLISA SureFire Ultra Human Total IR-β (Insulin Receptor Beta) Detection Kit, 500 Assay Points
AlphaLISA SureFire Ultra Human Total IR-β (Insulin Receptor Beta) Detection Kit, 500 Assay Points
Product information
Overview
Formats:
- The HV (high volume) kit contains reagents to run 100 wells in 96-well format, using a 60 µL reaction volume.
- The 500-point kit contains enough reagents to run 500 wells in 384-well format, using a 20 µL reaction volume.
- The 10,000-point kit contains enough reagents to run 10,000 wells in 384-well format, using a 20 µL reaction volume.
- The 50,000-point kit contains enough reagents to run 50,000 wells in 384-well format, using a 20 µL reaction volume.
In the AlphaLISA SureFire Ultra assay, Donor beads are coated with streptavidin to capture one of the antibodies, which is biotinylated. Acceptor beads are coated with a proprietary CaptSure™ agent that immobilizes the other antibody, labeled with a CaptSure™ tag. In the presence of target protein, the two antibodies bring the Donor and Acceptor beads close together, generating signal. The amount of light emission is directly proportional to the amount of protein present in the sample.
AlphaLISA SureFire Ultra™ kits are compatible with:
- Cell and tissue lysates
- Antibody modulators
- Biotherapeutic antibodies
Alpha SureFire kits can be used for:
- Cellular kinase assays
- Receptor activation studies
- Screening
Specifications
| Application |
Cell Signaling
|
|---|---|
| Automation Compatible |
Yes
|
| Brand |
AlphaLISA SureFire Ultra
|
| Detection Modality |
Alpha
|
| Lysis Buffer Compatibility |
Lysis Buffer
|
| Molecular Modification |
Total
|
| Product Group |
Kit
|
| Sample Volume |
10 µL
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Target |
Insulin Rec. β
|
| Target Class |
Phosphoproteins
|
| Target Species |
Human
|
| Technology |
Alpha
|
| Therapeutic Area |
Metabolic
|
| Unit Size |
500 Assay Points
|
Video gallery
AlphaLISA SureFire Ultra Human Total IR-β (Insulin Receptor Beta) Detection Kit, 500 Assay Points
AlphaLISA SureFire Ultra Human Total IR-β (Insulin Receptor Beta) Detection Kit, 500 Assay Points
Resources
Are you looking for resources, click on the resource type to explore further.
This guide outlines further possible optimization of cellular and immunoassay parameters to ensure the best possible results are...
Obesity is a complex condition characterized by excessive fat accumulation, posing significant health and socioeconomic challenges...
How can we help you?
We are here to answer your questions.
